2022 Expert Speakers

Alister Scott – Virtual Presenter

Senior IVD Development & Validation Manager

Almac Diagnostic Services

Andreas Stange

Vice President

TÜV SÜD

Bart Lubbers – Virtual Presenter

Project Manager

European Scientific Foundation for Laboratory Hemato Oncology

Caoimhe Vallely-Gilroy

Head of Digital Health & Therapeutics

Merck Healthcare KGaA

Carl Barrett

Vice President, Oncology

AstraZeneca

Chi Chen – Virtual Presenter

CDx Head at Oncology Precision Medicine

Bayer Pharmaceuticals

Chris Bagnall

Associate Principal Scientist, EMEA Biomarker Strategy & Applications

Ultivue

Chris Bray

Head Global Regulatory Affairs, Precision Medicine and Companion Diagnostics

Merck KGaA

Christopher Peters

Clinical Senior Lecturer & Consultant Upper GI Surgeon

Imperial College London

Claudia Dollins – Virtual Presenter

Executive Director, Regulatory Affairs, Companion Diagnostics & Precision Medicine

Bristol Myers Squibb

Clément Gay

Director of Business & Corporate Development

Stilla Technologies

Colin Weller

Vice President Partner Technologies

Medable

Dagmar Albers – Virtual Presenter

Diversity & Inclusion Lead UK

Pfizer

Daniel Andersson

PhD

University of Gothenburg

Ed Godber

Vice President Strategic Partnerships

Guardant Health

Emanuela Oldoni – Virtual Presenter

Scientific Programme Manager

European Infrastructure for Translational Medicine

Fabienne Hermitte

Senior Vice President, Global Quality & Regulatory Affairs & Head of Medical Affairs, Immuno-Oncology

Veracyte

Flora Berisha

Head of Dx Strategic Partnering, Oncology

Janssen, Global R&D

Geoff Dance

Field Applications Scientist Europe

Sengenics

Gillian Livock

Senior Vice President & GM, Connected Sensors and Digital Measures

Medable

Gregory Vladimir

Vice President, Translational Research

Exscientia

Ian Kavanagh

Chief Operating Officer

Apis Assay Technologies Ltd

Igor Rudychev – Virtual Presenter

Vice President of Enterprise Analytics

Horizon Therapeutics

Iñaki Gutiérrez-Ibarluzea – Virtual Presenter

Head

Osteba, Basque Office for HTA

Isabella Gashaw

Principal Clinical Biomarker Lead, Cardiometabolism

Boehringer Ingelheim

Jacob Bowry – Virtual Presenter

Diversity & Inclusion Undergraduate

Pfizer

James Hewitt

Senior CDx Specialist

TÜV SÜD

John Simmons

Global Vice President, Biopharma Business Development

Natera

Jonathan Dry

Vice President, Scientific Discovery

Tempus

Klaus Dücker

Senior director

Clinical Biomarkers & Companion Diagnostics Biopharma Business of Merck

Laura Benjamin

Chief Executive Officer

Oncxerna

Laurent Dercle – Virtual Presenter

Radiology Resident/Associate Research Scientist

NewYork-Presbyterian Hospital/Colombia University Irving Medical Center

Margaret Dellett

Clinical Project Manager

ARC Regulatory

Maria Orr

Head of Precision Medicine for Biopharmaceuticals

AstraZeneca

Matt Nelson

Senior Director, Companion Diagnostic Partnering

Illumina

Michael Hubank

Director, Clinical Genomics Research

The Royal Marsden NHS

Michael Kagey – Virtual Presenter

Senior Director of Translational Medicine

Leap Therapeutics

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology

Roche Tissue Diagnostics

Mike Wierzba – Virtual Presenter

Associate Director, Global Regulatory Affairs, Precision Medicine & Digital Health

GlaxoSmithKline

Mohini Rajasagi – Virtual Presenter

Senior Director Translational Oncology & Clinical Biomarkers

MSD

Norbert Farkas

Founder & Managing Partner

Centivis AG

Patrick Fivey

Director of Precision Medicine Policy

AstraZeneca

Philipp Schatz

Regulatory Strategist IVD

Bayer

Rafael Rosengarten

Chief Executive Officer

Genialis

Randolf Kerschbaumer – Virtual Presenter

Chief Executive Officer

OncoOne

Raquel Perez-Lopez

Principal Investigator

Vall d’Hebron Institute of Oncology

Rémi Rabeuf

Life Cycle Leader

Belgian Volition SRL

Reny Aniline

Senior Director, Business Development

Natera

Rob Slack

Vice President & Head of Pharmacology

Galecto

Sari Pesonen

Co-Founder & Chief Scientific Officer

Valo Therapeutics

Scott Reid

Vice President, Alliances & Companion Diagnostics

NeoGenomics

Sean Walsh

Chief Scientific Officer

Radiomics

Sir Mark Caulfield

Vice Principal (Health)

Queen Mary University of London

Stephanie Traub

Associate Director

UCB Pharma

Thomas Hach – Virtual Presenter

Executive Director

Novartis

Tricia Lucas-Clarke

Early Talent Recruitment Inclusion & Diversity Manager

GlaxoSmithKline

Una Pipic

Senior Vice President, International Oncology

Tempus Labs